Showing results (911-920 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|June 30, 2009
Identification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptideRonald C Hendrickson, Vito R Cicinnati, Andreas Albers, et al.Cancer Immunology, Immunotherapy : CII|June 25, 2009
Treatment combinations targeting apoptosis to improve immunotherapy of melanomaPeter Hersey, Xu Dong ZhangCancer Immunology, Immunotherapy : CII|April 11, 2009
2B4 (CD244) signaling via chimeric receptors costimulates tumor-antigen specific proliferation and in vitro expansion of human T cellsBianca Altvater, Silke Landmeier, Sibylle Pscherer, et al.Cancer Immunology, Immunotherapy : CII|April 14, 2009
The new face of nucleolin in human melanomaDorota Hoja-Łukowicz, Małgorzata Przybyło, Ewa Pocheć, et al.Cancer Immunology, Immunotherapy : CII|April 15, 2009
A genetic variant of immunoglobulin gamma2 is strongly associated with immunity to mucin 1 in patients with breast cancerJanardan P Pandey, Paul J Nietert, Kersti Klaamas, et al.Cancer Immunology, Immunotherapy : CII|March 31, 2009
Selected allogeneic dendritic cells markedly enhance human tumour antigen-specific T cell response in vitroAlban Gervais, Jean-Christophe Eymard, Eric Toulmonde, et al.Cancer Immunology, Immunotherapy : CII|March 26, 2009
Role of polymorphic Fc gamma receptor IIIa and EGFR expression level in cetuximab mediated, NK cell dependent in vitro cytotoxicity of head and neck squamous cell carcinoma cellsAndrés López-Albaitero, Steve C Lee, Sarah Morgan, et al.Cancer Immunology, Immunotherapy : CII|March 26, 2009
TGF-beta modulates the functionality of tumor-infiltrating CD8+ T cells through effects on TCR signaling and Spred1 expressionMaria Giovanna di Bari, M E Christine Lutsiak, Shinji Takai, et al.Cancer Immunology, Immunotherapy : CII|August 23, 2008
Aberrant expression of the hematopoietic-restricted minor histocompatibility antigen LRH-1 on solid tumors results in efficient cytotoxic T cell-mediated lysisIngrid M Overes, T Henriëtte Levenga, Johanna C M Vos, et al.Cancer Immunology, Immunotherapy : CII|August 16, 2008
Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapyConstantin N Baxevanis, Sonia A Perez, Michael PapamichailPageof 650